Advances in Economics, Management and Political Sciences
- The Open Access Proceedings Series for Conferences
Series Vol. 40 , 10 November 2023
* Author to whom correspondence should be addressed.
This paper makes an in-depth study of the US healthcare industry from both empirical and theoretical aspects of capital structure and investment value. By calculating the WACC (weighted average cost of capital) for three of the most representative public companies in the US healthcare industry (Johnson & Johnson, Pfizer, and UnitedHealth Group) and reviewing the literature, it is concluded that the company's business and capital flows have been affected due to the impact of the COVID-19 pandemic. At the same time, due to some differences in the main business and nature of the three companies, United Health Group found that it has the highest investment risk. Based on the analysis of the investment value and investment risk of Johnson & Johnson, Pfizer, and UnitedHealth Group, this paper provides more appropriate investment recommendations for investors with different preferences, to further understand the future development trend of the American medical industry.
capital structure, investment value, healthcare industry
1. K.L. Reiter, D. S., Capital investment strategies in health care systems. Retrieved from National Library of Medicine: https://pubmed.ncbi.nlm.nih.gov/10845384/, last accessed 2023/5/20.
2. Kerry Amato, E. D., Healthcare Investing Trends Report., https://www.himss.org/resources/healthcare-investing-trends-report, last accessed 2023/5/9.
3. RICHARD M. SCHEFFLER, L. M.: Soaring private equity investment in the healthcare sector: Consolidation accelerated competition undermined, and patients risk. pp. 4-7. (2021)
4. Johnson, T. D: U.S. not getting good value for its health care investment. Nation's Health, pp. Vol. 36 Issue 9, p6-7. (2006).
5. TurnerScottJason: Business risk and the trade-off theory of capital structure: Predicting the use of long-term debt in the healthcare sector. (2010).
6. Zucchi, K., Investing In The Healthcare Sector, https://www.investopedia.com/articles/stocks/08/investing-in-healthcare.asp, last accessed 2023/5/6.
7. Micca, P., Health-tech investment trends: A view into the Future of Health, https://www2.deloitte.com/us/en/blog/health-care-blog/2021/health-tech-investment-trends-a-view-into-the-future-of-health.html, last accessed 2023/5/6.
8. Togtokhsuren, T. (n.d.): Research Project in Finance: Johnson and Johnson Corporation.
9. Kapar, B. B.: Winners and losers from Pfizer and Biontech's vaccine announcement: Evidence from S&P 500 (Sub)sector indices. PLoS ONE, pp. Vol. 17 Issue 10, p1-23. 23p. (2022).
10. Stroh, P. J.: ENTERPRISE RISK MANAGEMENT AT UNITEDHEALTH GROUP. Strategic Finance, pp. Vol. 87 Issue 1, p26-35 (2005).
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).